An intramuscular vaccine needs to be administered in an appropriate site using a needle long enough to go through any subcutaneous fat yet not too long to go further than needed.
Site of Administration |
Age of the Patient |
---|---|
anterolateral thigh |
< 19 years |
deltoid muscle |
> 12 months |
Site |
Age of the Patient |
Sex and Weight |
Needle Length |
---|---|---|---|
anterolateral thigh |
< 1 month |
|
16 mm |
|
1 to 12 months |
|
25 mm |
|
1 to 2 years |
|
25 to 32 mm |
|
3 to 18 years |
|
25 to 32 mm |
deltoid muscle |
1 to 2 years |
|
16 to 25 mm |
|
3 to 18 years |
|
16 to 25 mm |
|
>= 19 years |
< 60 kg |
16 to 25 mm |
|
>= 19 years |
female 60-90 kg |
25 to 38 mm |
|
>= 19 years |
female > 90 kg |
38 mm |
|
>= 19 years |
male 60-118 kg |
25 to 38 mm |
|
>= 19 years |
male > 118 kg |
38 mm |
where:
• A shorter needle can be used if there is little subcutaneous fat.
• A longer needle can be used if there is a lot of subcutaneous fat.
Purpose: To select a location and needle length for administering an intramuscular vaccine.
Specialty: Infectious Diseases, Pharmacology, clinical
Objective: selection
ICD-10: Z23, Z24, Z25, Z26, Z27,